Tuesday, June 4, 2019

New diabetes clinical trial: Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes

Published on: June 04, 2019 at 07:00PM
Condition:   Type1diabetes
Intervention:   Drug: ProTrans
Sponsor:   NextCell Pharma Ab
Recruiting
By pippo at June 04, 2019
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)